Form 4: NeuroPace Inc. Executive Martha Morrell Reports Stock Disposal
SEC Form 4 Filing
Martha Morrell, Chief Medical Officer of NeuroPace Inc., reports disposing of 3,051 shares of common stock to cover tax obligations.
Summary
- On May 20, 2025, Martha Morrell, the Chief Medical Officer of NeuroPace Inc. (NPCE), disposed of 3,051 shares of common stock.
- The transaction was executed at a price of $17.99 per share.
- Following the transaction, Morrell directly owns 87,638 shares of NeuroPace Inc.
- The transaction was reported on a Form 4 filing with the SEC on May 21, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock disposal. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about an executive's transaction.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Disposals can occur for various reasons, including tax obligations or diversification of assets.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as executive stock transactions are often scrutinized for insights into company performance and management confidence.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of transaction: Martha Morrell disposed of shares. |
| 05/21/2025 | Date of Form 4 filing with the SEC. |
Keywords
Form 4, SEC Filing, Stock Disposal, NeuroPace Inc, NPCE, Martha Morrell, Chief Medical Officer, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.